Levetiracetam Teva (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. By modulating this protein, the drug stabilises neuronal firing and lowers the likelihood of excessive electrical activity that leads to seizures.

The appropriate dose of Levetiracetam Teva is determined individually by a qualified prescriber based on the patient’s age, weight, renal function, and seizure type. Patients should follow the dosing instructions provided by their healthcare professional.

Safety data for levetiracetam in pregnancy and lactation are limited. Prescribers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their doctor.

To request Levetiracetam Teva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It is generally well‑tolerated, has fewer drug‑enzyme interactions, and may be preferred when rapid titration or minimal hepatic metabolism is desired.

Levetiracetam Teva tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Levetiracetam Teva is taken orally, usually with or without food, as a tablet that is swallowed whole with water. The exact schedule—once, twice, or three times daily—depends on the prescriber’s instructions.

Serious adverse events can include severe allergic reactions, mood disturbances such as depression or suicidal thoughts, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience rash, swelling, mood changes, or breathing difficulties.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications without appropriate monitoring.